Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Fablyn (Lasofoxifene) – Investigational SERM

Drug (Brand / Generic)

Fablyn (lasofoxifene)

Company / Licensee

Pfizer and Ligand Pharmaceuticals

Therapy Class

SERM

Product Description

Oestrogen analogue

Current Indication

Prevention and treatment of osteoporosis in post-menopausal women

Market Sector

Metabolic

Development Status

Approved in Europe
Expand

Go Top